Axon Enterprise stock sits at an unusual valuation crossroads, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium to the current share price while market based multiples suggest the stock screens as undervalued.

• Axon Enterprise has returned 170.1% over the past 3 years, which puts more pressure on today’s price to justify expectations built into that run.
• Expectations for bookings growth, including from areas highlighted in recent brokerage commentary such as new products and international expansion, can support a richer valuation. However, any disappointment in converting those opportunities into sustained revenue and cash flows may weigh on what investors are willing to pay.
• With a low valuation score of 2 out of 6 checks, Axon Enterprise does not screen as a clear bargain on the broader set of valuation tests.

The issue now is whether Axon Enterprise’s current price better reflects the premium implied by the DCF intrinsic value estimate or the more cautious message from the broader valuation checks.

Is Axon Enterprise Getting Expensive on Cash Flow?

The Discounted Cash Flow (DCF) approach estimates what Axon Enterprise is worth today based on its projected future cash generation. For Axon Enterprise, the model starts from latest twelve month free cash flow of about $28.7 million and applies a growing cash flow profile, using a 2 Stage Free Cash Flow to Equity framework, to arrive at an intrinsic value estimate of roughly $426 per share.

Compared with the current share price, this implies the stock screens as about 15.4% overvalued on a pure cash flow basis. The strong bookings expectations highlighted in recent RBC Capital Markets commentary help explain why the market is comfortable paying more than what the Discounted Cash Flow (DCF) model suggests today.

On this model, Axon Enterprise currently looks overvalued relative to its projected cash flows.

Our Discounted Cash Flow (DCF) analysis suggests Axon Enterprise may be overvalued by 15.4%. Discover 38 high quality undervalued stocks or create your own screener to find better value opportunities.

Does Axon Enterprise Look Undervalued on Sales?

For Axon Enterprise, the P/S multiple fits well because investors often focus on revenue for fast growing, subscription heavy business models where earnings and free cash flow can lag sales.

Axon Enterprise trades at about 13.3x P/S, which is well above the Aerospace & Defense industry average of 5.3x but below the peer group average of 20.2x. The tailored fair P/S ratio for Axon Enterprise, which adjusts for its growth profile, margins, scale and risk, is around 16.4x, so the current multiple stands at a discount to that level.

This gap indicates that the market is valuing Axon Enterprise’s revenue stream more cautiously than the fair ratio implies, even with the stock already carrying a premium to the broader industry.

On the P/S framework, Axon Enterprise stock appears undervalued relative to the revenue multiple suggested by the fair ratio.

The Axon Enterprise Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Axon Enterprise pick up where this valuation puzzle leaves off by spelling out which growth, margin and earnings paths would need to play out for the stock to be worth materially more or less than today’s price. Each Narrative treats Axon Enterprise’s fair value as a thesis about the business that can be revisited over time, rather than a one off snapshot, and you will find them on Simply Wall St’s Community page.

Community views on Axon Enterprise sit far apart, with one camp seeing a repricing opportunity and the other warning expectations already look full.

Bull case: 26% undervalued

"Fast-track adoption of new Axon products such as Draft One, TASER 10, Axon Body 4, and Dedrone is driving up average deal values and product bundles per customer…"

Bear case: 15% overvalued

"The rapid commoditization of AI driven cameras, cloud storage, and real time analytics threatens to erode Axon's hardware and software competitive advantage…"

Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!

The Bottom Line

Axon Enterprise sits between a Discounted Cash Flow (DCF) intrinsic value estimate that points to an overvalued stock and market based multiples that still suggest undervalued revenue. The gap comes from what investors prioritise, with the intrinsic view hinging on the timing and sustainability of future cash flows, and the multiple view leaning on confidence in growth and how peers are priced. Broader valuation checks remain weak, so that single supportive sales multiple does not, on its own, make Axon Enterprise look like a clear bargain. The crux from here is whether Axon Enterprise can convert its opportunity set into durable cash generation that closes this valuation split.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.